Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 6/20 | 0.40 |
| ▸ | CA2 | P00918 | 6/20 | 0.40 |
| ▸ | EEF2K | O00418 | 2/20 | 0.40 |
| ▸ | EEF2 | P13639 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | PLK4 | O00444 | 1/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | TYK2 | P29597 | 1/20 | 0.37 |
| ▸ | FLT3 | P36888 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | ITK | Q08881 | 1/20 | 0.37 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL319282 | 0.98 | ACHE (0.45) | ACHECA1CA2EEF2KEEF2 | |
| Water SCHEMBL15365841 | 0.96 | ACHE (0.44) | ACHECA1CA2EEF2KEEF2 | |
| Bromide SCHEMBL8204076 | 0.96 | CA1 (0.44) | ACHECA1CA2EEF2KEEF2 | |
| Fluoride Ion SCHEMBL21980194 | 0.96 | ACHE (0.44) | ACHECA1CA2EEF2KEEF2 | |
| Hydrochloric Acid SCHEMBL1884666 | 0.96 | ACHE (0.47) | ACHECA1CA2EEF2KEEF2 | |
| SCHEMBL15732265 | 0.90 | ACHE (0.41) | ACHECA1CA2EEF2KEEF2 | |
| SCHEMBL28698375 | 0.90 | ACHE (0.41) | ACHECA1CA2EEF2KEEF2 | |
| SCHEMBL61367 | 0.90 | LMNA (0.42) | ACHECA1CA2EEF2KEEF2 | |
| SCHEMBL15348251 | 0.90 | ACHE (0.41) | ACHECA1CA2EEF2KEEF2 | |
| Iodide SCHEMBL596677 | 0.88 | EEF2K (0.48) | ACHECA1CA2EEF2KEEF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 964 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118335531-A | Fiber gel dye sensitized solar cell and preparation method thereof | 复旦大学 | 2024-07-12 | — | — | CN | claimed |
| CN-114999831-B | Fiber photo-anode, preparation method thereof and application thereof in solar cell | 复旦大学 | 2024-06-04 | — | — | CN | claimed |
| US-11913000-B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | IVERIC BIO, INC. (US) | 2024-02-27 | — | — | US | claimed |
| US-20240038453-A1 | DYE SENSITIZED SOLAR CELL, POLYMERIC SOLID-STATE ELECTROLYTE FILM FOR DYE SENSITIZED SOLAR CELL AND MANUFACTURING METHOD THEREOF | NATIONAL CHENG KUNG UNIVERSITY (TW) | 2024-02-01 | — | — | US | claimed |
| US-20240009613-A1 | CO2 CAPTURE SORBENTS WITH LOW REGENERATION TEMPERATURE AND HIGH DESORPTION RATES | AGARWAL, Shantanu | 2024-01-11 | — | — | US | claimed |
| CN-116631779-A | High-performance fiber dye sensitized solar cell and preparation method thereof | 复旦大学 | 2023-08-22 | — | — | CN | claimed |
| EP-4196246-A1 | <SUP2/>? <SUB2/>?2?COCAPTURE SORBENTS WITH LOW REGENERATION TEMPERATURE AND HIGH DESORPTION RATES | Susteon Inc. (US) | 2023-06-21 | — | — | EP | claimed |
| CN-110621317-B | Inhibitors of Histone Deacetylase (HDACS) | 安基生技新药股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-115996905-A | Phenylalkyl carbamate compounds for use in preventing or treating neurodegenerative diseases | 生物药品解决方案有限公司 | 2023-04-21 | — | — | CN | claimed |
| WO-2022254070-A1 | PHOTOCATALYST MATERIAL AND NANOMETRIC COATING OBTAINED THEREFROM | UNIVERSITAT DE VALÈNCIA (ES) | 2022-12-08 | — | — | WO | claimed |
| EP-2571904-A1 | NEW GEL ELECTROLYTES SUITABLE FOR PHOTOELECTROCHEMICAL DEVICES | Daunia Solar Cell S.r.l. (IT) | 2013-03-27 | — | — | EP | claimed |
| WO-2011145120-A1 | NEW GEL ELECTROLYTES SUITABLE FOR PHOTOELECTROCHEMICAL DEVICES | DAUNIA SOLAR CELL S.R.L. (IT) | 2011-11-24 | — | — | WO | claimed |
| WO-2011144306-A1 | NEW GEL ELECTROLYTES SUITABLE FOR PHOTOELECTROCHEMICAL DEVICES | DAUNIA SOLAR CELL S.R.L. (IT) | 2011-11-24 | — | — | WO | claimed |
| EP-1456861-B1 | A POLYMER GEL HYBRID SOLAR CELL | SONY DEUTSCHLAND GMBH (DE) | 2011-10-05 | — | — | EP | claimed |
| US-20110056563-A1 | ELECTROLYTE COMPOSITION | SOLARPRINT LIMITED (IE) | 2011-03-10 | — | — | US | claimed |
| US-20110031429-A1 | Use of exfoliated clay nanoplatelets and method for encapsulating cations | NATIONAL TAIWAN UNIVERSITY (TW) | 2011-02-10 | — | — | US | claimed |
| US-20100267849-A1 | GELATOR FOR PRODUCING A GEL ELECTROLYTE | NATIONAL CHENG KUNG UNIVERSITY (TW) | 2010-10-21 | — | — | US | claimed |
| US-7196264-B2 | Dye sensitized solar cell and method for manufacturing dye sensitized solar cell | KABUSHIKI KAISHA TOSHIBA (JP) | 2007-03-27 | — | — | US | claimed |
| US-20050109385-A1 | Dye-sensitized solar cell based on electrospun ultra-fine titanium dioxide fibers and fabrication method thereof | KOREAN INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2005-05-26 | — | — | US | claimed |
| EP-1528579-A2 | Dye-sensitized solar cell based on electrospun ultra-fine titanium dioxide fibers and fabrication method thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2005-05-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11913000-B2 | Aptamer therapeutics useful in the treatment of complement-related disorders | TTR, RNASE1, CLN6 | ACHE 4859/4885CA1 4830/4885CA2 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.